The pandemic spurred an urgency to innovate that improved clinical development in ways that should benefit the industry beyond COVID-19. The astonishing speed at which COVID-19 vaccines and new treatments went from discovery to FDA emergen-cy use authorization surprised the public. If drugs and vaccines take years to develop, how was the life science community able to create a novel vaccine and get multi-ple treatments approved in less than one year?

Join for free to read